4C LABS

4C LABS is a healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution, and clinical development of cannabis-based medicinal products (CBMP) for human health. 4C LABS is committed to advancing scientific research and facilitating the regulation, distribution, and prescription of CBPM in the UK and the Channel Islands. It collaborates with top scientists, specialists, and pharmacists using disruptive technologies that are driving a treatment approach prioritizing patients and evidence over stigma. 4C LABS works closely with the Academy of Pharmaceutical Sciences, the Cannabis Industry Council (CIC), the Medicines and Healthcare products Regulatory Agency (MHRA), and the Care Quality Commission (CQC) to promote safe and regulated changes in the medical field. 4C LABS holds an MS WDA, Schedule 1 narcotics, and manufacturing license in the UK.